Referencer
For mere information, klik på den respektive reference
- 1. Gregg et al. Non-invasive prenatal screening for fetal aneuploidy: 2016 update. Genet Med. (2016) doi:10.1038/gim.2016.9
- 2. Pavanello et al. Cell-free DNA screening for fetal aneuploidy using the rolling circle method: A step towards non invasive prenatal testing simplification
- 3. Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of Cell-Free DNA in Maternal Blood in Screening For Aneuploidies: Updated Meta-Analysis. Ultrasound Obstet Gynecol 2017 Sep;50(3):302-314. DOI: 10.1002/uog.17484
- 4. Dahl, F., et al. (2018): Imaging single DNA molecules for high precision NIPT. Scientific Reports 8: 4549. https://www.nature.com/articles/s41598-018-22606-0
- 5. Cuckle, H., Benn, P. & Pergament, E. Cell-free DNA screening for fetal aneuploidy as a clinical service. Clin Biochem 48, 932–941 (2015).
- 6. Dar, P. et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol 211, 527 e521–527 e517 (2014).
- 7. McCullough, R. M. et al. Non-invasive prenatal chromosomal aneuploidy testing–clinical experience: 100,000 clinical samples. PLoS One 9, e109173 (2014).
- 8. Revello, R., Sarno, L., Ispas, A., Akolekar, R. & Nicolaides, K. H. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result. Ultrasound Obstet Gynecol 47, 698–704 (2016).
- 9. Taneja, P. A. et al. Noninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85 000 cases. Prenat Diagn 36, 237–243 (2016).
- 10. Lo, Y. M. et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 104, 13116–13121 (2007).
- 11. Xu, C. et al. Noninvasive Prenatal Screening of Fetal Aneuploidy without Massively Parallel Sequencing. Clin Chem 63, 861–869 (2017).
- 12. Tong, Y. K. et al. Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker. PLoS One 5, e15244 (2010).
- 13. Wright et al. A unified approach to risk assessment for fetal aneuploidies. Ultrasound Obstet Gynecol 2015; 45: 48–54.
- 16. Padula et al. Retrospective study evaluating the performance of a first-trimester combined screening for trisomy 21 in an Italian unselected population
- 17. Gormus et al. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology
- 18. Pooh et al. Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study)
- 19. ACOG NIPT-Guidelines. American College of Obstetricians and Gynaecologists
- 20. Benn, P. Cuckle, H. & Pergament, E. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol 42, 15-33 (2013).
- 21. Huang et al. Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies. BMC Pregnancy and Childbirth volume 20, Article number: 713 (2020)
Vanadis NIPT – producentinformation – Læs mere her
Referenser fetal fraktion
- 13. Wright et al. A unified approach to risk assessment for fetal aneuploidies. Ultrasound Obstet Gynecol 2015; 45: 48–54.
- 14. Persson et al. Variability of “Reported Fetal Fraction ” in Noninvasive Prenatal Screening (NIPS), Clinical Chemistry, 2021; hvab014,
- 15. Hancock et al. Clinical Experience Across the Fetal-fraction Spectrum for a Non-invasive Prenatal Screen with Low Test-failure Rate. Ultrasound Obstet Gynecol 2020; 56:422-430
Forbind din klinik til Baby Screen®
Vi tilbyder dig, der er etableret, eller dig, der altid har tænkt på at starte dit eget, at blive medlem af Baby Screen. Vi tilbyder vores patienter et moderne og tiltalende koncept, hvor patientens informationsbehov og de mest højteknologiske analysemetoder er i fokus. Kontakt os, hvis du har brug for hjælp til at opsætte din Baby Screen-modtagelse.